Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

Half a degree and rapid socioeconomic development matter for heatwave risk.

Russo S, Sillmann J, Sippel S, Barcikowska MJ, Ghisetti C, Smid M, O'Neill B.

Nat Commun. 2019 Jan 11;10(1):136. doi: 10.1038/s41467-018-08070-4.

2.

The Erlangen Score Algorithm in the diagnosis and prediction of the progression from subjective cognitive decline and mild cognitive impairment to Alzheimer-type dementia.

Filipek-Gliszczyńska A, Barczak A, Budziszewska M, Mandecka M, Gabryelewicz T, Barcikowska M.

Folia Neuropathol. 2018;56(2):88-96. doi: 10.5114/fn.2018.76612.

3.

Plasma adiponectin array in women with Alzheimer's disease.

Baranowska-Bik A, Kalisz M, Martyńska L, Wolińska-Witort E, Styczyńska M, Chodakowska-Żebrowska M, Barcikowska M, Baranowska B, Bik W.

Endokrynol Pol. 2018;69(5):550-559. doi: 10.5603/EP.a2018.0055. Epub 2018 Aug 17.

4.

TREM2 variants in neurodegenerative disorders in the Polish population. Homozygosity and compound heterozygosity in FTD patients.

Peplonska B, Berdynski M, Mandecka M, Barczak A, Kuzma-Kozakiewicz M, Barcikowska M, Zekanowski C.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Aug;19(5-6):407-412. doi: 10.1080/21678421.2018.1451894. Epub 2018 Mar 20.

PMID:
29557178
5.

DNA methylation in ELOVL2 and C1orf132 correctly predicted chronological age of individuals from three disease groups.

Spólnicka M, Pośpiech E, Pepłońska B, Zbieć-Piekarska R, Makowska Ż, Pięta A, Karłowska-Pik J, Ziemkiewicz B, Wężyk M, Gasperowicz P, Bednarczuk T, Barcikowska M, Żekanowski C, Płoski R, Branicki W.

Int J Legal Med. 2018 Jan;132(1):1-11. doi: 10.1007/s00414-017-1636-0. Epub 2017 Jul 19.

6.

Combined use of biochemical and volumetric biomarkers to assess the risk of conversion of mild cognitive impairment to Alzheimer's disease.

Nesteruk M, Nesteruk T, Styczyńska M, Mandecka M, Barczak A, Barcikowska M.

Folia Neuropathol. 2016;54(4):369-374. doi: 10.5114/fn.2016.64815.

7.

Assessment of Olfactory Function in MAPT-Associated Neurodegenerative Disease Reveals Odor-Identification Irreproducibility as a Non-Disease-Specific, General Characteristic of Olfactory Dysfunction.

Markopoulou K, Chase BA, Robowski P, Strongosky A, Narożańska E, Sitek EJ, Berdynski M, Barcikowska M, Baker MC, Rademakers R, Sławek J, Klein C, Hückelheim K, Kasten M, Wszolek ZK.

PLoS One. 2016 Nov 17;11(11):e0165112. doi: 10.1371/journal.pone.0165112. eCollection 2016.

8.

Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.

Mandecka M, Budziszewska M, Barczak A, Pepłońska B, Chodakowska-Żebrowska M, Filipek-Gliszczyńska A, Nesteruk M, Styczyńska M, Barcikowska M, Gabryelewicz T.

J Alzheimers Dis. 2016 Jul 29;54(1):157-68. doi: 10.3233/JAD-160176.

PMID:
27472875
9.

Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders.

Ogaki K, Koga S, Heckman MG, Fiesel FC, Ando M, Labbé C, Lorenzo-Betancor O, Moussaud-Lamodière EL, Soto-Ortolaza AI, Walton RL, Strongosky AJ, Uitti RJ, McCarthy A, Lynch T, Siuda J, Opala G, Rudzinska M, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Puschmann A, Nishioka K, Funayama M, Hattori N, Parisi JE, Petersen RC, Graff-Radford NR, Boeve BF, Springer W, Wszolek ZK, Dickson DW, Ross OA.

Neurology. 2015 Dec 8;85(23):2016-25. doi: 10.1212/WNL.0000000000002170. Epub 2015 Nov 11.

10.

Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies.

Labbé C, Ogaki K, Lorenzo-Betancor O, Soto-Ortolaza AI, Walton RL, Rayaprolu S, Fujioka S, Murray ME, Heckman MG, Puschmann A, McCarthy A, Lynch T, Siuda J, Opala G, Rudzinska M, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Sanotsky Y, Rektorová I, McLean PJ, Rademakers R, Ertekin-Taner N, Hassan A, Ahlskog JE, Boeve BF, Petersen RC, Maraganore DM, Adler CH, Ferman TJ, Parisi JE, Graff-Radford NR, Uitti RJ, Wszolek ZK, Dickson DW, Ross OA.

Neurology. 2015 Nov 10;85(19):1680-6. doi: 10.1212/WNL.0000000000001946. Epub 2015 Sep 2. Erratum in: Neurology. 2015 Nov 10;85(19):1728.

11.

DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients.

Lorenzo-Betancor O, Ogaki K, Soto-Ortolaza AI, Labbe C, Walton RL, Strongosky AJ, van Gerpen JA, Uitti RJ, McLean PJ, Springer W, Siuda J, Opala G, Krygowska-Wajs A, Barcikowska M, Czyzewski K, McCarthy A, Lynch T, Puschmann A, Rektorova I, Sanotsky Y, Vilariño-Güell C, Farrer MJ, Ferman TJ, Boeve BF, Petersen RC, Parisi JE, Graff-Radford NR, Dickson DW, Wszolek ZK, Ross OA.

Eur J Neurol. 2015 Sep;22(9):1323-5. doi: 10.1111/ene.12770.

12.

Hypertension in patients with Alzheimer's disease--prevalence, characteristics, and impact on clinical outcome. Experience of one neurology center in Poland.

Warchol-Celinska E, Styczynska M, Prejbisz A, Przybylowska K, Chodakowska-Zebrowska M, Kurjata P, Piotrowski W, Polakowska M, Kabat M, Zdrojewski T, Drygas W, Januszewicz A, Barcikowska M.

J Am Soc Hypertens. 2015 Sep;9(9):711-24. doi: 10.1016/j.jash.2015.07.002. Epub 2015 Jul 9.

PMID:
26210391
13.

Is descriptive writing useful in the differential diagnosis of logopenic variant of primary progressive aphasia, Alzheimer's disease and mild cognitive impairment?

Sitek EJ, Barczak A, Kluj-Kozłowska K, Kozłowski M, Barcikowska M, Sławek J.

Neurol Neurochir Pol. 2015;49(4):239-44. doi: 10.1016/j.pjnns.2015.06.001. Epub 2015 Jun 17.

PMID:
26188940
14.

Writing in Richardson variant of progressive supranuclear palsy in comparison to progressive non-fluent aphasia.

Sitek EJ, Barczak A, Kluj-Kozłowska K, Kozłowski M, Narożańska E, Konkel A, Dąbrowska M, Barcikowska M, Sławek J.

Neurol Neurochir Pol. 2015;49(4):217-22. doi: 10.1016/j.pjnns.2015.05.004. Epub 2015 Jun 6.

PMID:
26188937
15.

Exonic Re-Sequencing of the Chromosome 2q24.3 Parkinson's Disease Locus.

Labbé C, Ogaki K, Lorenzo-Betancor O, Carrasquillo MM, Heckman MG, McCarthy A, Soto-Ortolaza AI, Walton RL, Lynch T, Siuda J, Opala G, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Dickson DW, Uitti RJ, Wszolek ZK, Ross OA.

PLoS One. 2015 Jun 19;10(6):e0128586. doi: 10.1371/journal.pone.0128586. eCollection 2015.

16.

Plasma leptin levels and free leptin index in women with Alzheimer's disease.

Baranowska-Bik A, Bik W, Styczynska M, Chodakowska-Zebrowska M, Barcikowska M, Wolinska-Witort E, Kalisz M, Martynska L, Baranowska B.

Neuropeptides. 2015 Aug;52:73-8. doi: 10.1016/j.npep.2015.05.006. Epub 2015 Jun 3.

PMID:
26070219
17.

Genetic variation of the retromer subunits VPS26A/B-VPS29 in Parkinson's disease.

Shannon B, Soto-Ortolaza A, Rayaprolu S, Cannon HD, Labbé C, Benitez BA, Choi J, Lynch T, Boczarska-Jedynak M, Opala G, Krygowska-Wajs A, Barcikowska M, Van Gerpen JA, Uitti RJ, Springer W, Cruchaga C, Wszolek ZK, Ross OA.

Neurobiol Aging. 2014 Aug;35(8):1958.e1-2. doi: 10.1016/j.neurobiolaging.2014.03.004. Epub 2014 Mar 5.

18.

ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease.

Medway CW, Abdul-Hay S, Mims T, Ma L, Bisceglio G, Zou F, Pankratz S, Sando SB, Aasly JO, Barcikowska M, Siuda J, Wszolek ZK, Ross OA, Carrasquillo M, Dickson DW, Graff-Radford N, Petersen RC, Ertekin-Taner N, Morgan K, Bu G, Younkin SG.

Mol Neurodegener. 2014 Mar 10;9:11. doi: 10.1186/1750-1326-9-11.

19.

GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16.

Soto-Ortolaza AI, Heckman MG, Labbé C, Serie DJ, Puschmann A, Rayaprolu S, Strongosky A, Boczarska-Jedynak M, Opala G, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Lynch T, Uitti RJ, Wszolek ZK, Ross OA.

Am J Neurodegener Dis. 2013 Nov 29;2(4):287-99. eCollection 2013.

20.

A novel MAPT mutation, G55R, in a frontotemporal dementia patient leads to altered Tau function.

Iyer A, Lapointe NE, Zielke K, Berdynski M, Guzman E, Barczak A, Chodakowska-Żebrowska M, Barcikowska M, Feinstein S, Zekanowski C.

PLoS One. 2013 Sep 27;8(9):e76409. doi: 10.1371/journal.pone.0076409. eCollection 2013.

21.

TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease.

Rayaprolu S, Mullen B, Baker M, Lynch T, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Josephs KA, Knopman DS, White CL 3rd, Caselli R, Mackenzie IR, Miller BL, Boczarska-Jedynak M, Opala G, Krygowska-Wajs A, Barcikowska M, Younkin SG, Petersen RC, Ertekin-Taner N, Uitti RJ, Meschia JF, Boylan KB, Boeve BF, Graff-Radford NR, Wszolek ZK, Dickson DW, Rademakers R, Ross OA.

Mol Neurodegener. 2013 Jun 21;8:19. doi: 10.1186/1750-1326-8-19.

22.

The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study.

Mroczko B, Groblewska M, Barcikowska M.

J Alzheimers Dis. 2013;37(2):273-83. doi: 10.3233/JAD-130647. Review.

PMID:
23792694
23.

LRRTM3 interacts with APP and BACE1 and has variants associating with late-onset Alzheimer's disease (LOAD).

Lincoln S, Allen M, Cox CL, Walker LP, Malphrus K, Qiu Y, Nguyen T, Rowley C, Kouri N, Crook J, Pankratz VS, Younkin S, Younkin L, Carrasquillo M, Zou F, Abdul-Hay SO, Springer W, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Lewis JM, Dickson D, Graff-Radford NR, Petersen RC, Eckman E, Younkin SG, Ertekin-Taner N.

PLoS One. 2013 Jun 4;8(6):e64164. doi: 10.1371/journal.pone.0064164. Print 2013.

24.

A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene.

Sitek EJ, Narożańska E, Pepłońska B, Filipek S, Barczak A, Styczyńska M, Mlynarczyk K, Brockhuis B, Portelius E, Religa D, Barcikowska M, Sławek J, Żekanowski C.

PLoS One. 2013 Apr 12;8(4):e61074. doi: 10.1371/journal.pone.0061074. Print 2013.

25.

TOMM40 and APOE common genetic variants are not Parkinson's disease risk factors.

Peplonska B, Safranow K, Gaweda-Walerych K, Maruszak A, Czyzewski K, Rudzinska M, Barcikowska M, Zekanowski C.

Neurobiol Aging. 2013 Aug;34(8):2078.e1-2. doi: 10.1016/j.neurobiolaging.2013.02.018. Epub 2013 Mar 21.

PMID:
23522842
26.

The prion protein M129V polymorphism: longevity and cognitive impairment among Polish centenarians.

Golanska E, Sieruta M, Corder E, Gresner SM, Pfeffer A, Chodakowska-Zebrowska M, Sobow TM, Klich I, Mossakowska M, Szybinska A, Barcikowska M, Liberski PP.

Prion. 2013 May-Jun;7(3):244-7. doi: 10.4161/pri.23903. Epub 2013 Feb 13.

27.

APBB2 genetic polymorphisms are associated with severe cognitive impairment in centenarians.

Golanska E, Sieruta M, Gresner SM, Pfeffer A, Chodakowska-Zebrowska M, Sobow TM, Klich I, Mossakowska M, Szybinska A, Barcikowska M, Liberski PP.

Exp Gerontol. 2013 Apr;48(4):391-4. doi: 10.1016/j.exger.2013.01.013. Epub 2013 Feb 4.

PMID:
23384821
28.

A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants.

Sharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, Bertram L, Bozi M, Barcikowska M, Crosiers D, Clarke CE, Facheris MF, Farrer M, Garraux G, Gispert S, Auburger G, Vilariño-Güell C, Hadjigeorgiou GM, Hicks AA, Hattori N, Jeon BS, Jamrozik Z, Krygowska-Wajs A, Lesage S, Lill CM, Lin JJ, Lynch T, Lichtner P, Lang AE, Libioulle C, Murata M, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Meitnger T, Zimprich A, Opala G, Pramstaller PP, Pichler I, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Satake W, Silburn PA, Strom TM, Theuns J, Tan EK, Toda T, Tomiyama H, Uitti RJ, Van Broeckhoven C, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yomono HS, Yueh KC, Zhao Y, Gasser T, Maraganore D, Krüger R; GEOPD consortium.

J Med Genet. 2012 Nov;49(11):721-6. doi: 10.1136/jmedgenet-2012-101155. Erratum in: J Med Genet. 2013 Mar;50(3):202.

29.

Agraphia in patients with frontotemporal dementia and parkinsonism linked to chromosome 17 with P301L MAPT mutation: dysexecutive, aphasic, apraxic or spatial phenomenon?

Sitek EJ, Narozanska E, Barczak A, Jasinska-Myga B, Harciarek M, Chodakowska-Zebrowska M, Kubiak M, Wieczorek D, Konieczna S, Rademakers R, Baker M, Berdynski M, Brockhuis B, Barcikowska M, Zekanowski C, Heilman KM, Wszolek ZK, Slawek J.

Neurocase. 2014;20(1):69-86. doi: 10.1080/13554794.2012.732087. Epub 2012 Nov 5.

30.

Identification of a late onset Alzheimer's disease candidate risk variant at 9q21.33 in Polish patients.

Gaj P, Paziewska A, Bik W, Dąbrowska M, Baranowska-Bik A, Styczynska M, Chodakowska-Żebrowska M, Pfeffer-Baczuk A, Barcikowska M, Baranowska B, Ostrowski J.

J Alzheimers Dis. 2012;32(1):157-68.

PMID:
22785395
31.

Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications.

Allen M, Zou F, Chai HS, Younkin CS, Miles R, Nair AA, Crook JE, Pankratz VS, Carrasquillo MM, Rowley CN, Nguyen T, Ma L, Malphrus KG, Bisceglio G, Ortolaza AI, Palusak R, Middha S, Maharjan S, Georgescu C, Schultz D, Rakhshan F, Kolbert CP, Jen J, Sando SB, Aasly JO, Barcikowska M, Uitti RJ, Wszolek ZK, Ross OA, Petersen RC, Graff-Radford NR, Dickson DW, Younkin SG, Ertekin-Taner N.

Mol Neurodegener. 2012 Apr 11;7:13. doi: 10.1186/1750-1326-7-13.

32.

PARK2 variability in Polish Parkinson's disease patients--interaction with mitochondrial haplogroups.

Gaweda-Walerych K, Safranow K, Jasinska-Myga B, Bialecka M, Klodowska-Duda G, Rudzinska M, Czyzewski K, Cobb SA, Slawek J, Styczynska M, Opala G, Drozdzik M, Nishioka K, Farrer MJ, Ross OA, Wszolek ZK, Barcikowska M, Zekanowski C.

Parkinsonism Relat Disord. 2012 Jun;18(5):520-4. doi: 10.1016/j.parkreldis.2012.01.021. Epub 2012 Feb 22.

33.

Conformational altered p53 as an early marker of oxidative stress in Alzheimer's disease.

Buizza L, Cenini G, Lanni C, Ferrari-Toninelli G, Prandelli C, Govoni S, Buoso E, Racchi M, Barcikowska M, Styczynska M, Szybinska A, Butterfield DA, Memo M, Uberti D.

PLoS One. 2012;7(1):e29789. doi: 10.1371/journal.pone.0029789. Epub 2012 Jan 5.

35.

TOMM40 rs10524523 polymorphism's role in late-onset Alzheimer's disease and in longevity.

Maruszak A, Pepłońska B, Safranow K, Chodakowska-Żebrowska M, Barcikowska M, Zekanowski C.

J Alzheimers Dis. 2012;28(2):309-22. doi: 10.3233/JAD-2011-110743.

PMID:
22008263
36.

The impact of mitochondrial and nuclear DNA variants on late-onset Alzheimer's disease risk.

Maruszak A, Safranow K, Branicki W, Gawęda-Walerych K, Pośpiech E, Gabryelewicz T, Canter JA, Barcikowska M, Zekanowski C.

J Alzheimers Dis. 2011;27(1):197-210. doi: 10.3233/JAD-2011-110710.

PMID:
21799244
37.

Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study.

Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, Crook JE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC, Passmore P, Morgan K; Alzheimer's Research UK (ARUK) consortium, Younkin SG.

Mol Neurodegener. 2011 Jul 28;6(1):54. doi: 10.1186/1750-1326-6-54.

38.

Paraoxonase gene polymorphism and the risk for Alzheimer's disease in the polish population.

Klimkowicz-Mrowiec A, Marona M, Wolkow P, Witkowski A, Maruszak A, Styczynska M, Barcikowska M, Szczudlik A, Slowik A.

Dement Geriatr Cogn Disord. 2011;31(6):417-23. doi: 10.1159/000329571. Epub 2011 Jul 13.

PMID:
21757906
39.

Death-associated protein kinase 1 variation and Parkinson's disease.

Dachsel JC, Wider C, Vilariño-Güell C, Aasly JO, Rajput A, Rajput AH, Lynch T, Craig D, Krygowska-Wajs A, Jasinska-Myga B, Opala G, Barcikowska M, Czyzewski K, Wu RM, Heckman MG, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA.

Eur J Neurol. 2011 Aug;18(8):1090-3. doi: 10.1111/j.1468-1331.2010.03255.x. Epub 2010 Nov 30.

PMID:
21749573
40.

Human leukocyte antigen variation and Parkinson's disease.

Puschmann A, Verbeeck C, Heckman MG, Soto-Ortolaza AI, Lynch T, Jasinska-Myga B, Opala G, Krygowska-Wajs A, Barcikowska M, Uitti RJ, Wszolek ZK, Ross OA.

Parkinsonism Relat Disord. 2011 Jun;17(5):376-8. doi: 10.1016/j.parkreldis.2011.03.008. Epub 2011 Apr 11.

41.

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.

Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, Thomas C, Richards A, Ivanov D, Widdowson C, Chapman J, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Beaumont H, Warden D, Wilcock G, Love S, Kehoe PG, Hooper NM, Vardy ER, Hardy J, Mead S, Fox NC, Rossor M, Collinge J, Maier W, Jessen F, Rüther E, Schürmann B, Heun R, Kölsch H, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Gallacher J, Hüll M, Rujescu D, Giegling I, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC; Alzheimer's Disease Neuroimaging Initiative, van Duijn CM, Breteler MM, Ikram MA, DeStefano AL, Fitzpatrick AL, Lopez O, Launer LJ, Seshadri S; CHARGE consortium, Berr C, Campion D, Epelbaum J, Dartigues JF, Tzourio C, Alpérovitch A, Lathrop M; EADI1 consortium, Feulner TM, Friedrich P, Riehle C, Krawczak M, Schreiber S, Mayhaus M, Nicolhaus S, Wagenpfeil S, Steinberg S, Stefansson H, Stefansson K, Snaedal J, Björnsson S, Jonsson PV, Chouraki V, Genier-Boley B, Hiltunen M, Soininen H, Combarros O, Zelenika D, Delepine M, Bullido MJ, Pasquier F, Mateo I, Frank-Garcia A, Porcellini E, Hanon O, Coto E, Alvarez V, Bosco P, Siciliano G, Mancuso M, Panza F, Solfrizzi V, Nacmias B, Sorbi S, Bossù P, Piccardi P, Arosio B, Annoni G, Seripa D, Pilotto A, Scarpini E, Galimberti D, Brice A, Hannequin D, Licastro F, Jones L, Holmans PA, Jonsson T, Riemenschneider M, Morgan K, Younkin SG, Owen MJ, O'Donovan M, Amouyel P, Williams J.

Nat Genet. 2011 May;43(5):429-35. doi: 10.1038/ng.803. Epub 2011 Apr 3.

42.

Replication of BIN1 association with Alzheimer's disease and evaluation of genetic interactions.

Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, Crook JE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC, Morgan K, Younkin SG.

J Alzheimers Dis. 2011;24(4):751-8. doi: 10.3233/JAD-2011-101932.

43.

Interleukin-6 gene (-174 C/G ) and apolipoprotein E gene polymorphisms and the risk of Alzheimer disease in a Polish population.

Klimkowicz-Mrowiec A, Wołkow P, Spisak K, Maruszak A, Styczyńska M, Barcikowska M, Szczudlik A, Słowik A.

Neurol Neurochir Pol. 2010 Nov-Dec;44(6):537-41.

PMID:
21225514
44.

An independent replication of PARK16 in Asian samples.

Vilariño-Güell C, Ross OA, Aasly JO, White LR, Rajput A, Rajput AH, Lynch T, Krygowska-Wajs A, Jasinska-Myga B, Opala G, Barcikowska M, Lee MC, Hentati F, Uitti RJ, Wszolek ZK, Farrer MJ, Wu RM.

Neurology. 2010 Dec 14;75(24):2248-9. doi: 10.1212/WNL.0b013e318202031f. No abstract available.

45.

Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease.

Luty AA, Kwok JB, Dobson-Stone C, Loy CT, Coupland KG, Karlström H, Sobow T, Tchorzewska J, Maruszak A, Barcikowska M, Panegyres PK, Zekanowski C, Brooks WS, Williams KL, Blair IP, Mather KA, Sachdev PS, Halliday GM, Schofield PR.

Ann Neurol. 2010 Nov;68(5):639-49. doi: 10.1002/ana.22274.

PMID:
21031579
46.

Ultrafiltrate of blood plasma modulates amyloid-β aggregation.

Nowicka A, Szczepankiewicz AA, Jaklewicz A, Filipek A, Barcikowska M, Elbaum D.

J Alzheimers Dis. 2011;23(1):1-5. doi: 10.3233/JAD-2010-101137.

PMID:
20930295
47.

Intra-familial clinical heterogeneity due to FTLD-U with TDP-43 proteinopathy caused by a novel deletion in progranulin gene (PGRN).

Gabryelewicz T, Masellis M, Berdynski M, Bilbao JM, Rogaeva E, St George-Hyslop P, Barczak A, Czyzewski K, Barcikowska M, Wszolek Z, Black SE, Zekanowski C.

J Alzheimers Dis. 2010;22(4):1123-33. doi: 10.3233/JAD-2010-101413.

48.

Cell cycle regulation distinguishes lymphocytes from sporadic and familial Alzheimer's disease patients.

Bialopiotrowicz E, Kuzniewska B, Kachamakova-Trojanowska N, Barcikowska M, Kuznicki J, Wojda U.

Neurobiol Aging. 2011 Dec;32(12):2319.e13-26. doi: 10.1016/j.neurobiolaging.2010.04.017. Epub 2010 Jun 11.

PMID:
20541838
49.

Association of pyridoxal kinase and Parkinson disease.

Vilariño-Güell C, Wider C, Aasly JO, White LR, Rajput A, Rajput AH, Lynch T, Krygowska-Wajs A, Jasinska-Myga B, Opala G, Barcikowska M, Czyzewski K, Wu RM, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA.

Ann Neurol. 2010 Mar;67(3):409-11. doi: 10.1002/ana.21962. No abstract available.

PMID:
20373354
50.

Increased CD44 gene expression in lymphocytes derived from Alzheimer disease patients.

Uberti D, Cenini G, Bonini SA, Barcikowska M, Styczynska M, Szybinska A, Memo M.

Neurodegener Dis. 2010;7(1-3):143-7. doi: 10.1159/000289225. Epub 2010 Mar 3.

PMID:
20197694

Supplemental Content

Loading ...
Support Center